Clinical Research Consultancy
Clinical Research Consultancy provides strategic, scientific, and operational guidance to pharmaceutical, biotechnology, and healthcare organizations throughout the clinical development lifecycle. Services commonly include trial design, regulatory strategy, protocol development, site management, data oversight, compliance support, and market authorization planning, helping clients accelerate research timelines, improve study quality, and reduce development risk.


Cell and gene therapies (CGTs) have been rapidly growing in recent years due to successful clinical results. As of Q4 2022, globally, 104 CGTs received full approval (excluding RNA therapy), 13 more are anticipated in the US and EU by the end of 2023 and more than 2,000 are currently in clinical trials. One of the fastest growing segments utilizes T cells; specifically, the use of chimeric antigen receptor (CAR) T cell immunotherapy for hematological malignancies.
